Cross-resistance between taxanes and new hormonal agents abiraterone and enzalutamide may affect drug sequence choices in metastatic castration-resistant prostate cancer-Reference-Cited by-同舟云学术

Cross-resistance between taxanes and new hormonal agents abiraterone and enzalutamide may affect drug sequence choices in metastatic castration-resistant prostate cancer

Published:2013-12 Issue:18 Volume:49 Page:3821-3830
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

van Soest R.J.,van Royen M.E.,de Morrée E.S.,Moll J.M.,Teubel W.,Wiemer E.A.C.,Mathijssen R.H.J.,de Wit R.,van Weerden W.M.

Funder

Sanofi

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference27 articles.

1. Antitumour activity of docetaxel following treatment with the CYP17A1 inhibitor abiraterone: clinical evidence for cross-resistance?;Mezynski;Ann Oncol,2012

2. Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer;Tannock;N Engl J Med,2004

3. Docetaxel and estramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer;Petrylak;N Engl J Med,2004

4. Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial;de Bono;Lancet,2010

5. Increased survival with enzalutamide in prostate cancer after chemotherapy;Scher;N Engl J Med,2012

Cited by 188 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Novel frontiers in urogenital cancers: from molecular bases to preclinical models to tailor personalized treatments in ovarian and prostate cancer patients;Journal of Experimental & Clinical Cancer Research;2024-05-15

2. Kinesin Facilitates Phenotypic Targeting of Therapeutic Resistance in Advanced Prostate Cancer;Molecular Cancer Research;2024-04-22

3. Natural course of metastatic castration‐resistant prostate cancer in the era of intensified androgen deprivation therapy in the hormone‐sensitive setting;The Prostate;2024-04

4. Prostate cancer androgen biosynthesis relies solely on CYP17A1 downstream metabolites;The Journal of Steroid Biochemistry and Molecular Biology;2024-02

5. Prostate Cancer Liver Metastasis: An Ominous Metastatic Site in Need of Distinct Management Strategies;Journal of Clinical Medicine;2024-01-27